Report cover image

Juvenile Macular Degeneration (JMD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Publisher GlobalData
Published Aug 04, 2023
Length 64 Pages
SKU # GBDT18144856

Description

Juvenile Macular Degeneration (JMD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape


Summary

This reports provides a data-driven overview of the current and future competitive landscape in JMD therapeutics.
  • More than 555,110 diagnosed prevalent cases of JMD are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for JMD.
  • There are significant unmet clinical need in the JMD treatment space due to a lack of marketed therapies.
  • R&D activity in the JMD space is very limited, with only six pipeline drugs in the mid-to-late-stage of development.
  • Clinical trial activity in JMD has been very limited during the past 10 years, with only 26 trials conducted overall.
    • Scope

    GlobalData’s Juvenile Macular Degeneration (JMD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

    Components of the report include -
    • Disease Landscape
    • Disease Overview
    • Epidemiology Overview
    • Treatment Overview
    • Marketed Products Assessment
    • Breakdown by Mechanism of Action, Route of Administration
    • Product Profiles with Sales Forecast
    • Pricing and Reimbursement Assessment
    • Annual Therapy Cost
    • Time to Pricing and Time to Reimbursement
    • Pipeline Assessment
    • Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
    • Product Profiles with Sales Forecast
    • Late-to-mid-stage Pipeline Drugs
    • Phase Transition Success Rate and Likelihood of Approval
    • Clinical Trials Assessment
    • Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
    • Enrolment Analytics, Site Analytics, Feasibility Analysis
    • Deals Landscape
    • Mergers, Acquisitions, and Strategic Alliances by Region
    • Overview of Recent Deals
    • Commercial Assessment
    • Key Market Players
    • Future Market Catalysts
    Reasons to Buy
    • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
    • Develop business strategies by understanding the trends shaping and driving the JMD market.
    • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global JMD market in the future.
    • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
    • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
    • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

    Table of Contents

    64 Pages
    1 Preface
    1.1 Contents
    1.2 Report Scope
    1.3 List of Tables and Figures
    1.4 Abbreviations
    2 Key Findings
    3 Disease Landscape
    3.1 Disease Overview
    3.2 Epidemiology Overview
    3.3 Treatment Overview
    4 Marketed Drugs Assessment
    5 Pricing and Reimbursement Assessment
    6 Pipeline Drugs Assessment
    6.1 Phase III Pipeline Drugs
    6.2 Overview by Development Stage
    6.3 Overview by Molecule Type
    6.4 Overview by Mechanism of Action
    6.5 Overview by Route of Administration
    6.6 Drug Specific Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA)
    6.7 Therapy Area and Indication-specific PTSR and LoA
    7 Clinical Trials Assessment
    7.1 Historical Overview
    7.2 Overview by Phase
    7.3 Overview by Status
    7.4 Overview by Phase for Ongoing and Planned Trials
    7.5 Trials with Virtual Components
    7.6 Geographic Overview
    7.7 Single-Country and Multinational Trials by Region
    7.8 Top 20 Sponsors with Breakdown by Phase
    7.9 Top 20 Sponsors with Breakdown by Status
    7.10 Overview by Endpoint Status
    7.11 Overview by Race and Ethnicity
    7.12 Enrollment Data
    7.13 Top 20 countries for Trial Sites
    7.14 Top 20 Sites Globally
    7.15 Feasibility Analysis – Geographic Overview
    7.16 Feasibility Analysis – Benchmark Models
    8 Deals Landscape
    8.1 Mergers, Acquisitions, and Strategic Alliances by Region
    8.2 Recent Mergers, Acquisitions, and Strategic Alliances
    9 Commercial Assessment
    9.1 Key Market Players
    10 Future Market Catalysts
    11 Appendix
    11.1 Methodology
    11.2 Methodology – Sales Forecast
    11.3 Methodology – Pricing and Reimbursement
    11.4 Methodology – PTSR and LoA Analysis
    11.5 About the Authors
    11.6 Contact Us
    11.7 Disclaimer

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Request A Sample
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us